This lecture introduces learners to the foundations of artificial intelligence (AI) in modern clinical research, focusing on how AI is transforming drug development, patient care, and clinical trial efficiency. Participants will explore the key AI concepts, including machine learning, deep learning, natural language processing, and predictive analytics, and understand how these tools are applied in patient recruitment, trial design, safety monitoring, and precision medicine. The lecture also highlights the importance of high-quality data, ethical considerations, and regulatory compliance when implementing AI in trials.

Key Learning Objectives:

• Understand the core principles of AI and machine learning in clinical research

• Explore real-world applications of AI in patient recruitment, trial design, and pharmacovigilance

• Recognize the role of predictive analytics and digital endpoints in optimizing clinical trials

• Identify ethical, privacy, and regulatory challenges in AI implementation

• Appreciate how AI enhances trial efficiency, safety, and data-driven decision-making

By the end of this lecture, learners will be equipped with a solid foundation to leverage AI for smarter, faster, and safer clinical trials.

This lecture focuses on how AI is revolutionizing patient recruitment and eligibility assessment in clinical trials. Learners will explore how machine learning, predictive analytics, and natural language processing can streamline patient identification, reduce screen failures, and accelerate enrolment. Emphasis is placed on using real-world data, EHRs, and digital tools to match eligible patients with suitable trials while maintaining ethical standards and regulatory compliance.

Key Learning Points:

• Role of AI in speeding up patient recruitment and reducing delays

• Predictive algorithms for eligibility scoring and patient stratification

• Leveraging EHRs, claims data, and wearables for real-time patient insights

• Reducing screen failure rates and optimising trial efficiency

• Ethical considerations including privacy, consent, and fairness

• Practical examples of AI applications in oncology, neurology, and multi-site trials

By the end of this lecture, learners will understand how AI-driven recruitment transforms trial efficiency, patient engagement, and data-driven decision-making.

This lecture explores how AI is revolutionising patient recruitment, eligibility screening, and enrolment efficiency in modern clinical trials. You’ll learn how machine learning, NLP, and predictive analytics streamline feasibility, accelerate patient matching, and reduce screen-failure rates. The session covers optimisation of inclusion/exclusion criteria, automated EHR mining, and real-world data insights that support equitable, faster, and more accurate recruitment strategies. Designed for clinical researchers, operations teams, and trial managers, this module highlights how AI brings speed, precision, and scalability to one of the most challenging parts of clinical development.

Key Highlights:

• AI-driven feasibility assessments & site selection

• Automated EHR mining for rapid patient matching

• Predictive analytics to forecast enrolment performance

• NLP tools for interpreting complex eligibility criteria

• Algorithms to minimise screen failures & dropout risk

• Ethical & regulatory considerations for data-driven recruitment

This session explores how artificial intelligence is transforming modern clinical trials through enhanced safety monitoring, precision medicine, and strong ethical governance. You’ll learn how AI improves pharmacovigilance, strengthens risk-based monitoring, and enables personalised treatment pathways using genomics, imaging, and EHR data. The session also covers regulatory expectations, emerging ethical frameworks, and best practices for responsible AI adoption in research settings.

Key Highlights:

• AI for real-time adverse event detection and signal prioritisation

• Machine learning models for patient stratification and biomarker discovery

• Predictive analytics for safety, efficacy, and early risk identification

• Integrating multi-modal data (EHR, omics, imaging) for precision medicine

• Ethical, regulatory, and governance considerations for AI deployment

• Practical guidance for clinical operations and research leaders

This lecture explores how AI and digital technologies are transforming clinical development, making trials faster, safer, and more patient-centred. Learners will understand the integration of predictive analytics, digital endpoints, and decentralised trial models to optimise study design, recruitment, and monitoring. Emphasis is placed on the strategic use of AI for trial efficiency, risk management, and personalised medicine, while maintaining regulatory compliance and ethical standards.

Key Learning Points:

• How AI accelerates clinical trials and improves decision-making

• Role of digital endpoints and wearable devices in patient monitoring

• Benefits of decentralised and hybrid trials for broader patient access

• Predictive modelling for risk mitigation and resource optimisation

• Future trends in precision medicine, biomarkers, and trial transformation

• Ethical and regulatory considerations for next-generation trials

By the end of this lecture, learners will appreciate how data-driven, AI-enabled clinical development shapes the future of drug discovery and patient-centred research.